Mindpeak

Mindpeak builds automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Their mission is to make microscopical and pathological AI-based analysis accessible for everyone in the world. The company's AI solutions assist cancer experts in providing reliable and reproducible diagnoses by automating tedious, repetitive tasks such as quantification of cells or biomarkers, allowing pathologists to focus on tasks where their human expertise is indispensable.

Founded in 2018 and based in Hamburg, Germany, Mindpeak develops AI-powered diagnostic software and integrates AI algorithms into histology-based IVDs, including companion diagnostics. Their solutions span across clinical diagnostics, translational research, and clinical trial services, helping to identify clinically relevant predictive biomarkers and supporting patient stratification.

The company's products include a comprehensive suite of AI tools for analyzing various types of cancer tissue, including breast, lung, gastric, and prostate cancer. These solutions are integrated with major digital pathology platforms worldwide, making Mindpeak one of the most integrated AI providers in pathology.